Canada markets closed

Epigenomics AG (EPGNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.35000.0000 (0.00%)
At close: 03:17PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.63M
Enterprise Value -11.12M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.86
Price/Book (mrq)0.35
Enterprise Value/Revenue -1.79
Enterprise Value/EBITDA 4.83

Trading Information

Stock Price History

Beta (5Y Monthly) 1.14
52-Week Change 3-75.69%
S&P500 52-Week Change 3-15.36%
52 Week High 31.4400
52 Week Low 30.3500
50-Day Moving Average 30.3732
200-Day Moving Average 30.4864

Share Statistics

Avg Vol (3 month) 3556
Avg Vol (10 day) 3N/A
Shares Outstanding 516.36M
Implied Shares Outstanding 6N/A
Float 810.21M
% Held by Insiders 137.02%
% Held by Institutions 15.07%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin -45.93%
Operating Margin (ttm)-106.12%

Management Effectiveness

Return on Assets (ttm)-27.23%
Return on Equity (ttm)-24.81%

Income Statement

Revenue (ttm)6.22M
Revenue Per Share (ttm)0.41
Quarterly Revenue Growth (yoy)7.70%
Gross Profit (ttm)6.07M
EBITDA -6.44M
Net Income Avi to Common (ttm)-2.86M
Diluted EPS (ttm)-0.2980
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.04M
Total Cash Per Share (mrq)1.1
Total Debt (mrq)1.01M
Total Debt/Equity (mrq)6.04
Current Ratio (mrq)5.84
Book Value Per Share (mrq)1.02

Cash Flow Statement

Operating Cash Flow (ttm)-5.88M
Levered Free Cash Flow (ttm)-2.35M